Business Description
G2GBIO Inc. is a South Korean biotech company founded in 2017 and based in Cheongju-si, focused on developing new medicines for serious human health conditions. Its drug pipeline targets a wide range of diseases, including Alzheimer's disease, type-2 diabetes, prostate cancer, osteoarthritis, hair loss, and Hepatitis B, as well as pain management solutions. The company is also advancing veterinary medicines, including drugs for animal castration and post-operative pain relief in animals.
